Literature DB >> 12879148

Membrane transplantation to correct integral membrane protein defects.

Kimberly V Curlee1, Jeong S Hong, J P Clancy, Scott A King, Eric Hunter, Bakhrom Berdiev, Dale Benos, Maja A Sommerfelt, Eric J Sorscher, Michael Sakalian.   

Abstract

In this report we show that the tendency of certain viruses to carry host membrane proteins in their envelopes can be harnessed for transplantation of small patches of plasma membrane, including fully functional, polytopic ion channel proteins and their regulatory binding partners. As a stringent model we tested the topologically complex epithelial ion channel CFTR. Initially an attenuated vaccinia virus was found capable of transferring CFTR in a properly folded, functional and regulatable form to CFTR negative cells. Next we generated viruslike particles (VLPs) composed of retroviral structural proteins that assemble and bud at the host cell plasma membrane. These particles were also shown to mediate functional ion channel transfer. By testing the capacity of complex membrane proteins to incorporate into viral envelopes these experiments provide new insight into the permissiveness of viral envelopment, including the ability of incorporated proteins to retain function and repair defects at the cell surface, and serve as a platform for studies of ion channel and membrane protein biochemistry.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879148     DOI: 10.1007/s00109-003-0446-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  36 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; Y Hamon; G Chimini
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

2.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway.

Authors:  J P Clancy; F E Ruiz; E J Sorscher
Journal:  Am J Physiol       Date:  1999-02

4.  Delta F508 CFTR localizes in the endoplasmic reticulum-Golgi intermediate compartment in cystic fibrosis cells.

Authors:  A Gilbert; M Jadot; E Leontieva; S Wattiaux-De Coninck; R Wattiaux
Journal:  Exp Cell Res       Date:  1998-07-10       Impact factor: 3.905

5.  E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells.

Authors:  F Sun; M J Hug; C M Lewarchik; C H Yun; N A Bradbury; R A Frizzell
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

6.  Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions.

Authors:  L Bastiani; S Laal; M Kim; S Zolla-Pazner
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Low-conductance chloride channels in IEC-6 and CF nasal cells expressing CFTR.

Authors:  J Bijman; W Dalemans; M Kansen; J Keulemans; E Verbeek; A Hoogeveen; H De Jonge; M Wilke; D Dreyer; J P Lecocq
Journal:  Am J Physiol       Date:  1993-03

8.  Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).

Authors:  G T Spear; N S Lurain; C J Parker; M Ghassemi; G H Payne; M Saifuddin
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

9.  Incorporation of CD4 into virions by a recombinant herpes simplex virus.

Authors:  K E Dolter; S R King; T C Holland
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia.

Authors:  B Jovov; I I Ismailov; D J Benos
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.